Bolton Securities’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-10,000
Closed -$214K – 2240
2026
Q2
$214K Hold
10,000
– – 0.01% 878
2026
Q1
$139K Hold
10,000
– – 0.01% 921
2025
Q4
$162K Buy
+10,000
New +$163K 0.01% 834

Other funds holding ADPT

Bolton Securities's ADPT Position: Q3 2026 in Review

Bolton Securities sold out of Adaptive Biotechnologies (ADPT) in Q3 2026, closing a stake of 10,000 shares — an estimated $214K sold.

Bolton Securities first reported a position in ADPT in Q4 2025 and held it in 3 quarters. The position peaked at $214K in Q2 2026. 334 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

  • Bolton Securities reported no remaining Adaptive Biotechnologies position as of Q3 2026 after selling out during the quarter.
  • Bolton Securities sold 10,000 Adaptive Biotechnologies shares in Q3 2026, an estimated $214K.
  • Bolton Securities first reported a position in Adaptive Biotechnologies in Q4 2025 and held it in 3 quarters.
  • Bolton Securities's Adaptive Biotechnologies position peaked at $214K in Q2 2026.
  • 334 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on Bolton Securities's 13F filing for Q3 2026, filed 12 Nov 2026.